We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$605M
AUM Growth
+$125M
Cap. Flow
+$96.3M
Cap. Flow %
15.91%
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.1M
2
INCY icon
Incyte
INCY
+$6.78M
3
TGT icon
Target
TGT
+$5.96M
4
RMD icon
ResMed
RMD
+$5.78M
5
MSCI icon
MSCI
MSCI
+$5.72M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$46.8M
2
WYNN icon
Wynn Resorts
WYNN
+$5.62M
3
AAPL icon
Apple
AAPL
+$5.53M
4
NVS icon
Novartis
NVS
+$5.28M
5
WMT icon
Walmart Inc
WMT
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 17.11%
3 Healthcare 16.08%
4 Industrials 11.44%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYL icon
676
Xylem
XYL
$27.3B
– –
-2,049
Closed -$215K
YOU icon
677
Clear Secure
YOU
$5.57B
– –
-35,029
Closed -$917K
ZTO icon
678
ZTO Express
ZTO
$18.3B
– –
-23,130
Closed -$663K
ZWS icon
679
Zurn Elkay Water Solutions
ZWS
$8.38B
– –
-10,174
Closed -$217K
VRN
680
DELISTED
Veren
VRN
– –
-73,578
Closed -$519K
TE
681
T1 Energy
TE
$1.16B
– –
-26,895
Closed -$239K
ONC
682
BeOne Medicines Ltd
ONC
$32.8B
– –
-1,246
Closed -$269K
XIFR
683
XPLR Infrastructure LP
XIFR
$1.12B
– –
-8,785
Closed -$534K
JOYY
684
JOYY Inc
JOYY
$3.71B
– –
-44,065
Closed -$1.37M
INFN
685
DELISTED
Infinera Corporation Common Stock
INFN
– –
-11,361
Closed -$88.2K
RCM
686
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-12,347
Closed -$185K
SILK
687
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-6,575
Closed -$257K
FSR
688
DELISTED
Fisker Inc.
FSR
– –
-58,415
Closed -$359K
SPLK
689
DELISTED
Splunk Inc
SPLK
– –
-8,273
Closed -$793K
MRTX
690
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-16,750
Closed -$623K
NEWR
691
DELISTED
New Relic, Inc.
NEWR
– –
-4,300
Closed -$324K
NATI
692
DELISTED
National Instruments Corp
NATI
– –
-13,227
Closed -$693K
NUVA
693
DELISTED
NuVasive, Inc.
NUVA
– –
-36,046
Closed -$1.49M
AQUA
694
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-17,192
Closed -$855K
PRVB
695
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-27,231
Closed -$656K
ESTE
696
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
– –
-15,618
Closed -$203K
24 25 26 27
28

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Seven Eight Capital held 696 positions worth $605M, up 26% from $480M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Seven Eight Capital deployed $96.3M of net new capital in Q2 2023, opening 282 new positions and adding to 102 existing holdings. Its largest new stake was AbbVie: 48,404 shares worth $6.52M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Carvana, an estimated $4.53M trimmed.

  • Seven Eight Capital's largest Q2 2023 buy was AbbVie: 48,404 shares worth $6.52M.
  • Seven Eight Capital added most to Las Vegas Sands in Q2 2023, an estimated $4.94M increase.
  • Seven Eight Capital's biggest Q2 2023 reduction was Carvana, cutting an estimated $4.53M.
  • Seven Eight Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $46.8M.
  • Seven Eight Capital's ten largest holdings make up 11% of its $605M portfolio in Q2 2023.
  • Seven Eight Capital opened 282 new positions and closed 224 in Q2 2023.
  • Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $605M.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.